NIP
AXSM icon

Nicholas Investment Partners’s Axsome Therapeutics AXSM Stock Holding History

Nicholas Investment Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2M Buy
98,974
+17,496
+21% +$3.79M 1.36% 9
2026
Q1 		$13.8M Sell
81,478
-10,086
-11% -$1.74M 0.99% 29
2025
Q4 		$16.7M Buy
91,564
+42,907
+88% +$5.99M 1.22% 12
2025
Q3 		$5.91M Buy
48,657
+6,503
+15% +$733K 0.45% 74
2025
Q2 		$4.4M Sell
42,154
-1,418
-3% -$150K 0.39% 103
2025
Q1 		$5.08M Buy
43,572
+33,437
+330% +$3.81M 0.52% 75
2024
Q4 		$858K Hold
10,135
– – 0.08% 189
2024
Q3 		$911K Buy
+10,135
New +$885K 0.08% 189
2024
Q2 		– Sell
-36,816
Closed -$2.94M – 199
2024
Q1 		$2.94M Sell
36,816
-45,829
-55% -$3.85M 0.3% 122
2023
Q4 		$6.58M Sell
82,645
-312,335
-79% -$20.9M 0.77% 38
2023
Q3 		$27.6M Buy
394,980
+96
+0% +$7.18K 2.06% 11
2023
Q2 		$28.4M Buy
394,884
+54,454
+16% +$4.02M 1.94% 13
2023
Q1 		$21M Buy
340,430
+140,176
+70% +$9.21M 1.6% 21
2022
Q4 		$15.4M Buy
+200,254
New +$12M 1.35% 22
2021
Q2 		– Sell
-138,571
Closed -$7.85M – 201
2021
Q1 		$7.85M Sell
138,571
-68,881
-33% -$4.85M 0.55% 60
2020
Q4 		$16.9M Buy
207,452
+19,696
+10% +$1.47M 1.31% 23
2020
Q3 		$13.4M Buy
187,756
+165,355
+738% +$12.9M 1.45% 22
2020
Q2 		$1.84M Sell
22,401
-34,400
-61% -$2.65M 0.37% 103
2020
Q1 		$3.34M Buy
56,801
+44,358
+356% +$3.61M 0.65% 61
2019
Q4 		$1.29M Buy
+12,443
New +$503K 0.13% 161

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Nicholas Investment Partners's AXSM Position: Q2 2026 in Review

Nicholas Investment Partners increased its Axsome Therapeutics (AXSM) stake by 21% in Q2 2026, buying an estimated $3.79M and bringing the position to 98,974 shares worth $24.2M. The position accounts for 1.36% of the portfolio, ranked #9.

Nicholas Investment Partners first reported a position in AXSM in Q4 2019 and has held it in 20 quarters since. The position peaked at $28.4M in Q2 2023. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Nicholas Investment Partners held 98,974 shares of Axsome Therapeutics worth $24.2M as of Q2 2026.
  • Nicholas Investment Partners bought 17,496 Axsome Therapeutics shares in Q2 2026, an estimated $3.79M.
  • Axsome Therapeutics made up 1.36% of Nicholas Investment Partners's portfolio in Q2 2026, its #9 holding.
  • Nicholas Investment Partners first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 20 quarters since.
  • Nicholas Investment Partners's Axsome Therapeutics position peaked at $28.4M in Q2 2023.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.